Log in or Sign up for Free to view tailored content for your specialty!
Skin Disorders News
Peach allergens, childhood asthma highlight EAACI congress research
The development of food allergy involving peach allergens and early prevention of asthma are among research topics to be presented at the European Academy of Allergy and Clinical Immunology annual congress that opens Saturday in Copenhagen, Denmark.
What is atopic dermatitis?
Atopic dermatitis, also called eczema, is a skin condition that mostly occurs in children but can continue into adulthood. It is characterized by itchy, dry, scaly patches on the skin.
Log in or Sign up for Free to view tailored content for your specialty!
‘Trapped’ allergy campaign kicks off EAACI annual congress
The European Academy of Allergy and Clinical Immunology and Asthma-Allergy Denmark have launched a campaign emphasizing that Europeans feel “trapped” by allergy.
Race determined response to step-up therapies in children with asthma, eczema
Children with asthma without a history of eczema responded best to long-acting B-agonist step-up therapy, while those with asthma and eczema had different responses based on race, according to study results.
Novartis reports 2014 Q1 sales, profit growth
Novartis reported a 1% increase in net sales to $14 billion in the first quarter of 2014, according to a press release.
US marshals seize unapproved dermatitis, eczema products
US marshals have seized more than $11 million worth of unapproved drugs, including creams and lotions intended to treat dermatitis and eczema, at the request of the FDA and the US Attorney for the Southern District of Ohio.
Amgen, AstraZeneca: Brodalumab effectively treated psoriasis patients
Brodalumab treatment in patients with moderate-to-severe plaque psoriasis met primary and secondary endpoints for disease improvement when compared with placebo, according to phase 3 study results from Amgen and AstraZeneca.
Allergens induced differential T-cell activation in patch tests
Allergens may induce differential T-cell activation in reactive tests, recently published data suggest.
Investigational guselkumab neutralized IL-23, improved psoriasis
Guselkumab demonstrated clinically meaningful response in patients with moderate-to-severe psoriasis, suggesting that the neutralization of interleukin-23 alone could be a promising therapy, according to researchers.
NIH physician and immunologist to receive molecular medicine award
John J. O’Shea, MD, scientific director at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, will receive the second annual Ross Prize in Molecular Medicine.
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read
-
Headline News
‘Please talk about it’: Patients with heart disease want more guidance on sexual health
November 26, 20242 min read -
Headline News
Breast calcification on mammogram ‘especially predictive’ of CVD risk in younger women
November 26, 20243 min read -
Headline News
Q&A: How to talk to families about vaccines
November 26, 20245 min read